ReviewPlanta2026
Plant isopropylmalate synthases: in and beyond leucine biosynthesis.
Review in Planta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Primary metabolic enzymes in amino acid biosynthesis pathways are involved in amino acid synthesis and maintenance of metabolic homeostasis through feedback regulatory mechanisms. The genes encoding these enzymes are also known to undergo functional diversification through evolutionary processes to encode specific secondary metabolic enzymes. One such enzyme is α-isopropylmalate synthase (α-IPMS), which catalyzes and regulates leucine (Leu) biosynthesis in eubacteria, archaebacteria, fungi, and plants, and has served as an evolutionary progenitor for specialized enzymes in distinct secondary metabolic pathways. However, most information on IPMS comes from the bacterial research community, particularly in the context of Leu overproduction or as a target for developing drugs against tuberculosis. In plants, only a few studies have reported on IPMS, focusing primarily on its role in regulating Leu homeostasis. Herein, we review the complex regulatory network that exists in Leu metabolism, focusing on the regulation of its biosynthesis and its key regulatory enzyme, IPMS. This review also highlights how evolution has independently recruited IPMS for specialized metabolism in several plant lineages. Finally, we describe the emerging roles of IPMS as a candidate for engineering amino acid and yield-related traits in crop plants. We also identify important open questions in this area that remain to be addressed.
Indexed as
Identifiers
41936719What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.